What Is the agilon health, inc. (AGL) Class Action Lawsuit About?
[et_pb_section admin_label=”section”]
[et_pb_row admin_label=”row”]
[et_pb_column type=”4_4″][et_pb_text admin_label=”Text”]Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired agilon securities between February 26, 2025, and August 4, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case.
What Does the agilon health, inc. Securities Class Action Allege?
According to the Complaint, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that:
- Defendants recklessly issued guidance for 2026 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware;
- Defendants materially overstated the immediate positive financial impact from “strategic actions” taken by agilon to reduce risk; and
- as a result, defendants’ statements about agilon’s business, operations, and prospects were materially false and/or misleading at all times.
What’s Next for agilon Investors?
A class action lawsuit has already been filed. You may review a copy of the Complaint. You may also contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911. If you suffered a loss in agilon you have until March 2, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff.
How Is agilon (NYSE: AGL) Stock Trading Today?
Interactive chart showing the weekly share price history of AGL (AGL).
How Is BG&G Representing Investors in Securities Class Actions?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”